During the past decade, Nij Smellinghe conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nij Smellinghe" #1 sponsor was "Nij Smellinghe Hosptial" with 4 trials, followed by "University Medical Center Groningen" with 3 trials sponsored, "Borstkanker Onderzoek Groep" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Rijnstate Hospital" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nij Smellinghe" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "ALMANAC Trialists Group" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Agendia" with 1 trials as a collaborator and "Amphia, Breda, the Netherlands" with 1 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Nij Smellinghe" are "Breast Cancer" (3 trials), "Lymphedema" (3 trials), "Multiple Myeloma" (2 trials), "Abdominal Pain" (1 trials) and "Acute Thrombosis of Deep Veins of Proximal Lower Extremity" (1 trials). Many other conditions were trialed in "Nij Smellinghe" in a lesser frequency.

Most popular intervention types in "Nij Smellinghe" are "Drug" (7 trials), "Procedure" (5 trials), "Device" (3 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Acetylsalicylic acid" (1 trials), "Application of Integuseal sealant" (1 trials) and "Blood sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nij Smellinghe" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Nij Smellinghe". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Nij Smellinghe, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nij Smellinghe, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".